What Is MIBG Therapy?
MIBG therapy (also known as 131I-MIBG therapy) is a form of radionuclide therapy currently being used in patients with a few types of cancer.
MIBG therapy (also known as 131I-MIBG therapy) is a form of radionuclide therapy currently being used in patients with a few types of cancer.
A small quantity of MIBG (meta-iodobenzylguanidine) molecule attached to radioactive iodine-131 is injected intravenously into the patient. The MIBG molecule targets the radiation of Iodine-131 (131I) to the cancer target sites. The delivered radiation then kills the cancer cells.
MIBG therapy is relatively safe. However, like all treatments it is not free of side effects and benefit of therapy needs to be measured against risk of side effects before giving this treatment. However, overall the side effect profile is quite encouraging.
MIBG therapy has been used for over 3 decades. MIBGtherapy use over time has led to good scientificevidence supporting its effectiveness. This has led to ever increasing interest in and use of MIBG therapy.
Psma Therapy Is Currently Used in Patients With Neuroblastoma, Pheochromocytoma and Paraganglioma.